Bio-Techne Corporation ROCE Ratio 2011-2026 | TECH

Annual ROCE Ratio Bio-Techne Corporation

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
5.33	9.99	15.2	17.44	15.1	11.4	8.25	8.88	10.16	14.0	14.36	18.87	20.95	24.0	27.2

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
27.2	5.33	14.74

Quarterly ROCE Ratio Bio-Techne Corporation

2025-Q4	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
8.97	8.54	6.07	9.4	10.8	10.46	8.06	12.3	13.22	15.0	11.18	18.48	19.51	19.46	20.08	20.77	19.88	19.57	19.14	14.84	14.01	13.45	12.56	11.66	10.95	11.22	11.05	11.32	10.8	10.16	10.52	9.87	10.26	9.85	10.4	9.81	9.99	12.19	12.64	15.06	15.83	15.83	16.57	16.66	17.43	17.99	18.97	19.47	20.38	20.92	21.05	21.68	21.94	22.94	24.33	25.29	26.67	6.95	6.43	6.99

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
26.67	6.07	14.63

ROCE Ratio of other stocks in the Biotechnology industry

Issuer	ROCE Ratio	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	2.89	-	2.43 %	$ 254 M	Germany
Xeris Pharmaceuticals XERS	181.87	$ 6.03	-1.55 %	$ 885 M	USA
UroGen Pharma Ltd. URGN	118.38	$ 19.2	-11.52 %	$ 554 M	Israel
uniQure N.V. QURE	-24.32	$ 10.89	-30.36 %	$ 530 M	Niderland
GT Biopharma GTBP	-214.65	$ 0.47	-2.41 %	$ 892 K	USA
Alexion Pharmaceuticals, Inc. ALXN	17.36	-	-	$ 40.3 B	USA
Biophytis SA BPTS	-325.06	-	-13.47 %	$ 169 M	France
AbCellera Biologics ABCL	-16.8	$ 3.74	3.6 %	$ 1.12 B	Canada
EyeGate Pharmaceuticals, Inc. EYEG	-61.36	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	-337.43	-	-18.52 %	$ 27.3 M	Britain
Adverum Biotechnologies ADVM	-196.79	-	-	$ 86.2 M	USA
Институт стволовых клеток человека ISKJ	15.18	-	-	-	Russia
ARCA biopharma ABIO	-23.06	-	1052.0 %	$ 415 M	USA
Acer Therapeutics ACER	146.85	-	2.71 %	$ 14 M	USA
Alpine Immune Sciences ALPN	-32.41	-	-	$ 2.17 B	USA
Acorda Therapeutics ACOR	167.74	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	-25.04	-	4.01 %	$ 150 M	Canada
CureVac N.V. CVAC	-51.5	-	-	$ 867 M	Germany
Aeterna Zentaris AEZS	-29.95	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	-180.78	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	-29.3	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	-60.13	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	-28.92	-	1.93 %	$ 17.4 M	USA
Agenus AGEN	99.51	$ 3.36	0.86 %	$ 1.2 M	USA
Ayala Pharmaceuticals AYLA	3412.47	-	-	$ 7.46 M	Israel
Akero Therapeutics AKRO	-38.05	-	-	$ 3.67 B	USA
Agios Pharmaceuticals AGIO	-39.57	$ 29.16	-3.54 %	$ 1.69 B	USA
Advaxis ADXS	429.74	-	-9.65 %	$ 45.9 M	USA
Akouos AKUS	-37.16	-	0.23 %	$ 488 M	USA
Завод ДИОД DIOD	5.84	-	-	-	Russia
Фармсинтез LIFE	-4.03	-	-	-	Russia
Albireo Pharma ALBO	-70.32	-	-0.23 %	$ 916 M	USA
Alector ALEC	-509.01	$ 2.19	-9.77 %	$ 226 M	USA
Entera Bio Ltd. ENTX	-159.29	$ 1.38	-0.72 %	$ 63.3 M	Israel
Allena Pharmaceuticals ALNA	-252.54	-	3.16 %	$ 1.9 M	USA
Aileron Therapeutics ALRN	-119.71	-	10.36 %	$ 9.8 M	USA
Altimmune ALT	-80.08	$ 4.21	-2.32 %	$ 299 M	USA
Teligent, Inc. TLGT	69.22	-	-13.85 %	$ 16.1 M	USA
AlloVir ALVR	-57.76	-	4.14 %	$ 49.1 M	USA
Evogene Ltd. EVGN	-39.87	$ 0.84	-4.24 %	$ 27.9 M	Israel
Viela Bio, Inc. VIE	-40.79	-	-	$ 2.91 B	USA
Ampio Pharmaceuticals AMPE	-75.24	-	-11.43 %	$ 502 K	USA
Amarin Corporation plc AMRN	-10.92	$ 13.98	1.27 %	$ 5.7 B	Irlanda
AbbVie ABBV	-461.01	$ 233.57	0.64 %	$ 413 B	USA
Blueprint Medicines Corporation BPMC	-60.1	-	-	$ 8.14 B	USA
Applied Molecular Transport AMTI	-209.11	-	-	$ 10.1 M	USA
AIM ImmunoTech AIM	-51.79	$ 0.8	-11.6 %	$ 38.5 M	USA
Apellis Pharmaceuticals APLS	14.97	$ 20.67	-1.38 %	$ 2.61 B	USA